Your search returned 6 results.

Results
	1.	Confirmation of model-based dose selection for a Japanese phase III study of rivaroxaban in non-valvular atrial fibrillation patients. [electronic resource] by Kaneko, Masato Tanigawa, Takahiko Hashizume, Kensei Kajikawa, Mariko Tajiri, Masahiro Mueck, Wolfgang Producer: 20140429 In: Drug metabolism and pharmacokinetics vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation. [electronic resource] by Tanigawa, Takahiko Kaneko, Masato Hashizume, Kensei Kajikawa, Mariko Ueda, Hitoshi Tajiri, Masahiro Paolini, John F Mueck, Wolfgang Producer: 20130814 In: Drug metabolism and pharmacokinetics vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer. [electronic resource] by Yamada, Yasuhide Kiyota, Naomi Fuse, Nozomu Kato, Ken Minami, Hironobu Hashizume, Kensei Kuroki, Yoshihiro Ito, Yuichiro Ohtsu, Atsushi Producer: 20140813 In: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer. [electronic resource] by Matsubara, Nobuaki Mukai, Hirofumi Hosono, Ako Onomura, Mai Sasaki, Masaoki Yajima, Yoko Hashizume, Kensei Yasuda, Masanobu Uemura, Miho Zurth, Christian Producer: 20171201 In: Cancer chemotherapy and pharmacology vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics. [electronic resource] by Sunakawa, Yu Furuse, Junji Okusaka, Takuji Ikeda, Masafumi Nagashima, Fumio Ueno, Hideki Mitsunaga, Shuichi Hashizume, Kensei Ito, Yuichiro Sasaki, Yasutsuna Producer: 20141007 In: Investigational new drugs vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer. [electronic resource] by Matsubara, Nobuaki Mukai, Hirofumi Hosono, Ako Onomura, Mai Sasaki, Masaoki Yajima, Yoko Hashizume, Kensei Yasuda, Masanobu Uemura, Miho Zurth, Christian Publication details: Cancer chemotherapy and pharmacology 12 2017 In: Cancer chemotherapy and pharmacology vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)